PLXNA3 was another gene upregulated in the majority of the tested cancers and the increased expression was associated with worse OS and PFI of COAD, KIRC, brain lower grade glioma (LGG), MESO, SARC, UCEC, uveal carcinosarcoma (UVM), and PRAD. Here, PLXNA3 is linked to prostate adenocarcinoma.